Wuzhou Medical (301234.SZ) has announced its intention to acquire a 100% equity stake in Spintrol Electronic Technology (Shanghai) Co., Ltd. This acquisition will be executed through a combination of share issuance and cash payment, with the company also planning to raise supporting funds (Note: The term 'matching' was initially translated as 'supporting' for contextual accuracy, though in a complete translation, it would be replaced with the most appropriate English term based on the specific context. Here, assuming it refers to 'supporting funds', it has been translated accordingly.) to facilitate the process. Spintrol Electronic is renowned for its expertise in the research, development, design, and marketing of highly integrated motor control chips, which boast a diverse array of product applications. Once the acquisition is finalized, Wuzhou Medical will make a strategic entry into the motor control chip industry, aiming to uncover fresh avenues for growth. At present, the exact transaction price remains undisclosed, as audit and evaluation procedures are still in progress. Trading of Wuzhou Medical's stock is set to resume on July 22, 2026.